Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 11.894 Q1 | 261 | 274 | 720 | 8837 | 6963 | 277 | 23.74 | 32.25 |  |
| 2 | Pharmacology and Therapeutics | journal | 4.266 Q1 | 169 | 137 | 345 | 25165 | 3755 | 334 | 10.70 | 183.69 | |
| 3 | Neuropsychopharmacology | journal | 3.566 Q1 | 188 | 329 | 978 | 18624 | 5520 | 873 | 5.73 | 56.61 | |
| 4 | Natural Product Reports | journal | 3.458 Q1 | 141 | 79 | 240 | 10352 | 2226 | 227 | 9.55 | 131.04 | |
| 5 | Molecular Therapy | journal | 3.215 Q1 | 146 | 247 | 751 | 10786 | 4107 | 582 | 6.48 | 43.67 | |
| 6 | Particle and Fibre Toxicology | journal | 2.742 Q1 | 67 | 69 | 179 | 4493 | 1629 | 168 | 8.35 | 65.12 | |
| 7 | Emerging Microbes and Infections | journal | 2.278 Q1 | 22 | 56 | 141 | 1488 | 575 | 115 | 4.91 | 26.57 | |
| 8 | Neuropharmacology | journal | 2.264 Q1 | 141 | 453 | 1271 | 30314 | 5980 | 1219 | 4.98 | 66.92 | |
| 9 | Journal of Antimicrobial Chemotherapy | journal | 2.240 Q1 | 160 | 485 | 1614 | 14710 | 6761 | 1371 | 4.99 | 30.33 | |
| 10 | F1000 Biology Reports | journal | 2.128 Q1 | 22 | 0 | 2 | 0 | 12 | 2 | 0.00 | 0.00 | |
| 11 | Advanced healthcare materials | journal | 1.906 Q1 | 41 | 340 | 687 | 17355 | 3547 | 653 | 5.20 | 51.04 | |
| 12 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.876 Q1 | 63 | 19 | 44 | 1932 | 249 | 42 | 5.46 | 101.68 | |
| 13 | Critical Reviews in Toxicology | journal | 1.799 Q1 | 90 | 39 | 129 | 5075 | 655 | 117 | 5.22 | 130.13 | |
| 14 | Environmental Pollution | journal | 1.786 Q1 | 170 | 1061 | 1497 | 51692 | 7718 | 1416 | 5.17 | 48.72 | |
| 15 | Expert Opinion on Therapeutic Targets | journal | 1.709 Q1 | 70 | 119 | 383 | 12656 | 1615 | 369 | 4.29 | 106.35 | |
| 16 | PharmacoEconomics | journal | 1.697 Q1 | 86 | 114 | 324 | 4712 | 897 | 261 | 3.77 | 41.33 | |
| 17 | Nanotoxicology | journal | 1.594 Q1 | 59 | 150 | 297 | 8051 | 1665 | 290 | 5.64 | 53.67 | |
| 18 | Clinical Pharmacokinetics | journal | 1.560 Q1 | 141 | 139 | 288 | 6804 | 1301 | 247 | 5.05 | 48.95 | |
| 19 | Toxicological Sciences | journal | 1.530 Q1 | 151 | 231 | 822 | 10742 | 3158 | 763 | 3.90 | 46.50 | |
| 20 | Addictive Behaviors | journal | 1.530 Q1 | 103 | 259 | 875 | 10607 | 2650 | 863 | 3.05 | 40.95 | |
| 21 | Expert Opinion on Drug Delivery | journal | 1.469 Q1 | 75 | 149 | 413 | 11820 | 2238 | 398 | 5.35 | 79.33 | |
| 22 | Expert Review of Vaccines | journal | 1.464 Q1 | 66 | 143 | 421 | 11331 | 1286 | 386 | 3.11 | 79.24 | |
| 23 | British Journal of Clinical Pharmacology | journal | 1.460 Q1 | 121 | 326 | 837 | 12400 | 2827 | 717 | 3.52 | 38.04 | |
| 24 | International Journal of Neuropsychopharmacology | journal | 1.457 Q1 | 86 | 105 | 802 | 6042 | 2327 | 758 | 2.62 | 57.54 | |
| 25 | Drug Safety | journal | 1.445 Q1 | 108 | 118 | 338 | 6297 | 1103 | 277 | 4.11 | 53.36 | |
| 26 | Therapeutic Advances in Neurological Disorders | journal | 1.387 Q1 | 31 | 47 | 87 | 2058 | 367 | 81 | 4.83 | 43.79 | |
| 27 | Pharmacogenomics Journal | journal | 1.352 Q1 | 74 | 139 | 231 | 3909 | 894 | 226 | 3.60 | 28.12 | |
| 28 | Human Genomics | journal | 1.297 Q1 | 39 | 22 | 92 | 780 | 240 | 75 | 3.25 | 35.45 | |
| 29 | Clinical Toxicology | journal | 1.265 Q1 | 79 | 149 | 471 | 3513 | 1142 | 300 | 4.12 | 23.58 | |
| 30 | Journal for ImmunoTherapy of Cancer | journal | 1.211 Q1 | 13 | 92 | 121 | 4056 | 280 | 113 | 2.67 | 44.09 | |
| 31 | Antiviral Therapy | journal | 1.198 Q1 | 75 | 100 | 356 | 2851 | 789 | 343 | 2.08 | 28.51 | |
| 32 | Alcohol and Alcoholism | journal | 1.195 Q1 | 85 | 67 | 352 | 2328 | 802 | 314 | 2.23 | 34.75 | |
| 33 | Journal of Nanobiotechnology | journal | 1.187 Q1 | 45 | 82 | 209 | 4601 | 987 | 202 | 4.73 | 56.11 | |
| 34 | Expert Opinion on Investigational Drugs | journal | 1.175 Q1 | 90 | 128 | 419 | 11124 | 1413 | 406 | 3.55 | 86.91 | |
| 35 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.174 Q1 | 75 | 110 | 268 | 3482 | 744 | 252 | 2.64 | 31.65 | |
| 36 | Expert Opinion on Biological Therapy | journal | 1.138 Q1 | 70 | 145 | 513 | 11318 | 1600 | 491 | 3.22 | 78.06 | |
| 37 | Neurotoxicity Research | journal | 1.101 Q1 | 57 | 104 | 226 | 7666 | 702 | 218 | 2.94 | 73.71 | |
| 38 | Expert Opinion on Drug Discovery | journal | 1.096 Q1 | 42 | 105 | 309 | 9743 | 1078 | 305 | 3.51 | 92.79 | |
| 39 | Expert Opinion on Therapeutic Patents | journal | 1.034 Q1 | 57 | 110 | 331 | 9821 | 1236 | 326 | 3.03 | 89.28 | |
| 40 | Drug Testing and Analysis | journal | 1.030 Q1 | 34 | 198 | 440 | 4596 | 1194 | 400 | 3.40 | 23.21 | |
| 41 | Expert Review of Clinical Pharmacology | journal | 1.016 Q1 | 26 | 158 | 233 | 11088 | 602 | 208 | 2.73 | 70.18 | |
| 42 | Mutagenesis | journal | 1.013 Q2 | 79 | 66 | 233 | 3191 | 561 | 226 | 2.36 | 48.35 | |
| 43 | BioDrugs | journal | 1.008 Q2 | 57 | 50 | 149 | 2995 | 442 | 136 | 3.07 | 59.90 | |
| 44 | Expert Opinion on Pharmacotherapy | journal | 0.997 Q2 | 64 | 243 | 757 | 17781 | 2148 | 719 | 3.19 | 73.17 | |
| 45 | Journal of Toxicology and Environmental Health - Part A | journal | 0.982 Q2 | 74 | 113 | 361 | 5159 | 963 | 358 | 2.68 | 45.65 | |
| 46 | Bioorganic and Medicinal Chemistry | journal | 0.978 Q1 | 129 | 720 | 2334 | 28704 | 6864 | 2274 | 2.97 | 39.87 | |
| 47 | Future Medicinal Chemistry | journal | 0.953 Q2 | 44 | 167 | 581 | 11194 | 1385 | 454 | 3.03 | 67.03 | |
| 48 | BMC pharmacology & toxicology | journal | 0.951 Q2 | 17 | 62 | 191 | 2499 | 459 | 187 | 2.33 | 40.31 | |
| 49 | Tetrahedron | journal | 0.907 Q2 | 198 | 1049 | 3594 | 53815 | 9009 | 3508 | 2.69 | 51.30 | |
| 50 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.904 Q2 | 63 | 142 | 407 | 11370 | 1247 | 399 | 3.08 | 80.07 | |
Powered by:
Follow us on Twitter
Scimago Lab, Copyright 2007-2017. Data Source: Scopus®
Download data